Back to top of page

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

- Investigate and mitigate challenges facing clinical assay development and analytical validation

- Preanalytical variability in tumor tissue biopsies, blood biospecimens, or other biospecimens

- Preanalytical variability associated with small biopsies, blood utilized for "liquid biopsies", tissue swabs, tissue secretions, pleural and esophageal aspirates, feces, sweat, urine, CSF, breast milk, and saliva

- How different biospecimen preanalytical conditions affect biomarkers

- Quantification of clinically relevant biomarkers by various testing platforms

- Results to improve understanding of how analytical quantification of biomarkers is affected by variation in biospecimen collection, processing, and storage procedures

- Evidence-based standardization of biopsy handling practices for expedited biomarker clinical assay development.

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows